Affiliation: | 1. https://orcid.org/0000-0001-7089-3703;2. Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Heart Centre, Amsterdam, The Netherlands;3. Doris ?kori?‐Milosavljevi?, Amsterdam UMC, University of Amsterdam, Heart Centre, Department of Clinical and Experimental Cardiology, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands.;4. Alex V. Postma, Amsterdam UMC, University of Amsterdam, Department of Clinical Genetics, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands.;5. Department of Pediatric Cardiology, Amsterdam UMC, Emma Children's Hospital, Amsterdam, The Netherlands;6. Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands;7. Department of Medical Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands;8. Department of Pediatric Cardiology, Leiden University Medical Center, Leiden, The Netherlands;9. Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands |
Abstract: | The first human mutations in GATA6 were described in a cohort of patients with persistent truncus arteriosus, and the phenotypic spectrum has expanded since then. This study underscores the broad phenotypic spectrum by presenting two patients with de novo GATA6 mutations, both exhibiting complex cardiac defects, pancreatic, and other abnormalities. Furthermore, we provided a detailed overview of all published human genetic variation in/near GATA6 published to date and the associated phenotypes (n = 78). We conclude that the most common phenotypes associated with a mutation in GATA6 were structural cardiac and pancreatic abnormalities, with a penetrance of 87 and 60%, respectively. Other common malformations were gallbladder agenesis, congenital diaphragmatic hernia, and neurocognitive abnormalities, mostly developmental delay. Fifty‐eight percent of the mutations were de novo, and these patients more often had an anomaly of intracardiac connections, an anomaly of the great arteries, and hypothyroidism, compared with those with inherited mutations. Functional studies mostly support loss‐of‐function as the pathophysiological mechanism. In conclusion, GATA6 mutations give a wide range of phenotypic defects, most frequently malformations of the heart and pancreas. This highlights the importance of detailed clinical evaluation of identified carriers to evaluate their full phenotypic spectrum. |